Back to Emergency Medicine
Emergency Medicinev2010Evidence-Based

ROSE (Risk Stratification of Syncope in the Emergency Department) Rule

Predicts 1-month serious outcome or death in patients presenting with syncope to the emergency department. The ROSE rule identifies high-risk patients who require admission and further workup versus those who can be safely discharged. This validated clinical decision tool uses 7 readily available clinical variables to stratify syncope patients and reduce unnecessary admissions while identifying those at risk for serious cardiovascular outcomes.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
rose risk assessment
—risk level
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The ROSE (Risk Stratification of Syncope in the Emergency Department) Rule is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within emergency medicine.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

ROSE Rule = Presence of ANY of the following: (1) BNP ≥300 pg/ml OR (2) Bradycardia ≤50 bpm OR (3) Positive fecal occult blood OR (4) Hemoglobin ≤90 g/l OR (5) Chest pain with syncope OR (6) Q wave on ECG (not lead III) OR (7) Oxygen saturation ≤94%

Clinical Pearls & Practice Notes

  • ROSE rule predicts 1-month serious outcome or death in syncope patients
  • ANY positive criterion indicates high risk requiring admission consideration
  • Original validation showed 87.2% sensitivity and 65.5% specificity
  • Negative predictive value of 98.5% for serious outcomes
  • BNP is the strongest single predictor (OR 7.3)
  • Positive fecal occult blood has highest odds ratio (OR 13.2)
  • Serious outcomes occurred in 7.1-7.3% of study patients
  • Rule requires BNP testing which may not be readily available in all EDs
  • Consider in conjunction with clinical judgment and other risk factors
  • Validated in emergency department setting for adult patients
  • Does not replace clinical assessment for other admission indications
  • Chest pain criterion refers to pain associated temporally with syncope
  • Q waves in lead III are specifically excluded due to positional artifacts
  • Oxygen saturation must be measured on room air for accuracy
  • Bradycardia criterion includes pre-hospital documentation by EMS
  • Anemia threshold corresponds to WHO definition for severe anemia
  • Fecal occult blood testing recommended if GI bleeding suspected
  • Rule performance may vary in different healthcare systems and populations
  • Follow-up studies have examined troponin as additional predictor
  • Consider other syncope risk stratification tools if ROSE unavailable

Evidence & Literature Citations

  1. Reed MJ, Newby DE, Coull AJ, Prescott RJ, Jacques KG, Gray AJ. The ROSE (risk stratification of syncope in the emergency department) study. J Am Coll Cardiol. 2010 Feb 23;55(8):713-21. doi: 10.1016/j.jacc.2009.09.049.
  2. Reed MJ, Mills NL, Weir CJ. Sensitive troponin assay predicts outcome in syncope. Emerg Med J. 2012 Dec;29(12):1001-3. doi: 10.1136/emermed-2011-200456.
  3. Colivicchi F, Ammirati F, Melina D, Guido V, Imperoli G, Santini M; OESIL (Osservatorio Epidemiologico sulla Sincope nel Lazio) Study Investigators. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J. 2003 May;24(9):811-9. doi: 10.1016/s0195-668x(02)00713-0.

Score Interpretation Ranges

Low Risk0 – 0 pts

No ROSE criteria present

High Risk1 – 7 pts

One or more ROSE criteria present

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.